In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Endocardial Solutions Inc.

Latest From Endocardial Solutions Inc.

St. Jude To Bring All Devices Under One Roof

St. Jude Medical plans to combine its implantable electronic device unit with its cardiovascular/ablation unit into one integrated R&D organization, and announced several senior leadership changes as part of the restructuring.

Medical Device

Endosense: Growing Up Fast in AF

Hoping to succeed in the elusive field of atrial fibrillation, Endosense is taking an anti-start-up strategy: focusing more on later-stage commercialization and market launch and less on technology vetting.

Medical Device

Reviewing 2005: The Top Medical Device Stories

The device industry was robust in 2005. Share prices remain strong for the most part--some orthopedics and cardiovascular companies struggled, but for the most part device stock indices continue strong--and the IPO window for start-ups remains open. New technology is flowing and so are venture dollars. Certainly, the device industry has had few instances of the kinds of bad news that Big Pharma and biotechs have struggled with: investor frustration, high-profile pipeline problems, and general industry struggles to find a viable long-term strategy, with a couple of exceptions. The battle for Guidant was widely-reported precisely because Guidant ran into problems with its ICD line, which caused Johnson & Johnson to hesitate and opened the door for a rival bid from Boston Scientific. Similarly, conflict of interest stories were featured in several general business publications, all with a decidedly negative spin. We don't share the view that conflict of interest is a real problem-just the opposite: physician involvement in device development is the lifeblood of the industry.

Leadership Platform Technologies

Symphony Medical Inc.

The founders of Symphony Medical asked themselves how they could improve outcomes in atrial fibrillation patients with a procedure that would be faster than current ablative techniques and which wouldn't destroy heart tissue. The solution lies in a biopolymer that can achieve a biological effect on the heart, and it came, in a roundabout way, from cell therapy work begun in heart failure.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies